Combined effect of zoledronic acid and telomerase-specific oncolytic virotherapy for human osteosarcoma cells.

被引：1
作者：
Yamakawa, Yasuaki [1 ]
Hasei, Joe [1 ]
Tazawa, Hiroshi [2 ]
Osaki, Shuhei [1 ]
Sasaki, Tsuyoshi [1 ]
Kunisada, Toshiyuki [3 ]
Yoshida, Aki [1 ]
Urata, Yasuo [4 ]
Ozaki, Toshifumi [1 ]
Fujiwara, Toshiyoshi [5 ]
机构：
[1] Okayama Univ, Grad Sch, Dept Orthopaed Surg, Okayama 7008530, Japan
[2] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[3] Okayama Univ, Grad Sch, Dept Med Mat Musculoskeletal Reconstruct, Okayama 7008530, Japan
[4] Oncolys BioPharma Inc, Tokyo, Japan
[5] Okayama Univ, Grad Sch, Dept Gastroenterol Surg, Okayama 7008530, Japan
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-3320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3320
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Telomerase-specific replication-selective virotherapy for human cancer
    Kawashima, T
    Kagawa, S
    Kobayashi, N
    Shirakiya, Y
    Umeoka, T
    Teraishi, F
    Kyo, S
    Taki, M
    Tanaka, N
    Fujiwara, T
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 285 - 292
  • [22] ANTITUMOR EFFECT OF TELOMERASE-SPECIFIC ONCOLYTIC ADENOVIRUS ON HUMAN BONE AND SOFT TISSUE SARCOMA CELLS
    Tazawa, Hiroshi
    Sasaki, Tsuyoshi
    Hasei, Jo
    Hashimoto, Yuuri
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8) : 261 - 262
  • [23] Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy
    Tazawa, Hiroshi
    Hasei, Joe
    Yano, Shuya
    Kagawa, Shunsuke
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCERS, 2020, 12 (02)
  • [24] Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
    Watanabe, Y.
    Hashimoto, Y.
    Kagawa, S.
    Kawamura, H.
    Nagai, K.
    Tanaka, N.
    Urata, Y.
    Fujiwara, T.
    CANCER GENE THERAPY, 2012, 19 (11) : 767 - 772
  • [25] Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
    Y Watanabe
    Y Hashimoto
    S Kagawa
    H Kawamura
    K Nagai
    N Tanaka
    Y Urata
    T Fujiwara
    Cancer Gene Therapy, 2012, 19 : 767 - 772
  • [26] Telomerase-specific virotherapy in an animal model of human head and neck cancer
    Nakajima, Oumi
    Matsunaga, Atsuko
    Ichimaru, Daiju
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Kawakami, Koji
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (01) : 171 - 177
  • [27] Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Kure, Miho
    Kondo, Hiroya
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Yoshida, Aki
    Kunisada, Toshiyuki
    Urata, Yasuo
    Kagawa, Shunsuke
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (05) : 1405 - 1417
  • [28] Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma
    Yusuke Mochizuki
    Hiroshi Tazawa
    Koji Demiya
    Miho Kure
    Hiroya Kondo
    Tadashi Komatsubara
    Kazuhisa Sugiu
    Joe Hasei
    Aki Yoshida
    Toshiyuki Kunisada
    Yasuo Urata
    Shunsuke Kagawa
    Toshifumi Ozaki
    Toshiyoshi Fujiwara
    Cancer Immunology, Immunotherapy, 2021, 70 : 1405 - 1417
  • [29] Telomerase-specific replication-selective virotherapy combined with radiation therapy for oral squamous cell carcinoma cells
    Kurihara, Yuji
    Sato, Daisuke
    Shirota, Tatsuo
    Kondo, Seiji
    Kataoka, Masafumi
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Shintani, Satoru
    CANCER RESEARCH, 2012, 72
  • [30] A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System
    Ikeda, Yoshihiro
    Kojima, Toru
    Kuroda, Shinji
    Endo, Yoshikatsu
    Sakai, Ryo
    Hioki, Masayoshi
    Kishimoto, Hiroyuki
    Uno, Futoshi
    Kagawa, Shunsuke
    Watanabe, Yuichi
    Hashimoto, Yuuri
    Urata, Yasuo
    Tanaka, Noriaki
    Fujiwara, Toshiyoshi
    JOURNAL OF IMMUNOLOGY, 2009, 182 (03) : 1763 - 1769
12345